Investors shift focus from gene therapy to lucrative weight-loss drugs ...Middle East

The News - Cultural
Investors shift focus from gene therapy to lucrative weight-loss drugs
A researcher works in Dr. John Tisdale's lab at the National Institutes of Health after the agency announced a breakthrough in sickle cell anemia research in Bethesda, US on March 11, 2019. — ReutersGene therapy, which promises a possible cure for rare diseases like sickle cell, is...

Read More Details
Finally We wish PressBee provided you with enough information of ( Investors shift focus from gene therapy to lucrative weight-loss drugs )

Also on site :

Most viewed in Cultural


Latest News
before 3 hours & 24 minute